Verwiel Frank
SEC insider (Form 3/4/5 filer). CIK 0001545794. Director at Intellia Therapeutics, Inc. (NTLA). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in CAMBRIDGE, MA.
Companies Verwiel Frank has filed insider reports for
- Intellia Therapeutics, Inc. (NTLA): Director
Verwiel Frank
CIK: 0001545794
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NTLA
Intellia Therapeutics, Inc.
Director